Paul B. Rothman, M.D.
Dr. Paul Rothman is the dean of the medical faculty for the Johns Hopkins University School of Medicine and chief executive officer of Johns Hopkins Medicine, a $9 billion academic medical enterprise and health system with a global reach. As dean/CEO, Dr. Rothman oversees both the Johns Hopkins Health System and the school of medicine. A rheumatologist and molecular immunologist, he came to Johns Hopkins in 2012, after serving as dean of the Carver College of Medicine at the University of Iowa. Previously, he served as head of internal medicine at the University of Iowa, and prior to that, as vice chairman for research and founding director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons, where he joined the faculty in 1990.
A 1980 Phi Beta Kappa graduate of the Massachusetts Institute of Technology, Rothman received his Medical degree from Yale University in 1984, earning a place in the Alpha Omega Alpha Honor Medical Society. He then trained at New York-Presbyterian/Columbia University Irving Medical Center in internal medicine and rheumatology and accepted a postdoctoral fellowship at Columbia University prior to joining its medical school faculty.
Rothman's research focused on immune system molecules, known as cytokines. Specifically, he investigated the role these molecules play in the normal development of blood cells, as well as the abnormal development of these blood cells that leads to leukemia.
Dr. Rothman is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Society for Clinical Investigation. He served as president of the Association of American Physicians; was elected as a fellow of the American Association for the Advancement of Sciences; and is the current president of the Society of Medical Administrators. In addition, Dr. Rothman serves on the boards of Merck, as well as the King Faisal Specialty Hospital, for which he receives compensation.